Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method

Introduction. Tadalafil is a drug used to treat erectile dysfunction. For the quantitative determination of tadalafil in human plasma are used methods of high performance liquid chromatography with ultraviolet and tandem mass spectrometric detection, during the analytical part of pharmacokinetic stu...

Full description

Saved in:
Bibliographic Details
Main Authors: D. S. Bogdanova, T. N. Komarov, I. E. Shohin, E. S. Melnikov, O. A. Miskiv, Yu. V. Medvedev
Format: Article
Language:Russian
Published: LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-05-01
Series:Разработка и регистрация лекарственных средств
Subjects:
Online Access:https://www.pharmjournal.ru/jour/article/view/690
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849243913085255680
author D. S. Bogdanova
T. N. Komarov
I. E. Shohin
E. S. Melnikov
O. A. Miskiv
Yu. V. Medvedev
author_facet D. S. Bogdanova
T. N. Komarov
I. E. Shohin
E. S. Melnikov
O. A. Miskiv
Yu. V. Medvedev
author_sort D. S. Bogdanova
collection DOAJ
description Introduction. Tadalafil is a drug used to treat erectile dysfunction. For the quantitative determination of tadalafil in human plasma are used methods of high performance liquid chromatography with ultraviolet and tandem mass spectrometric detection, during the analytical part of pharmacokinetic studies. In the majority of the considered methods the method of liquid-liquid extraction and the method of solid-phase extraction are used, these methods are difficult and expensive. Therefore, the method of protein precipitation was considered as sample preparation. This method is simple and there is important to analysis a lot of clinical samples in bioequivalence studies.Aim. The aim of this study is to develop method for the quantitative determination of tadalafil in human plasma by HPLC-MS for the analytical part of pharmacokinetic studies.Materials and methods. Quantitative determination of tadalafil in plasma by HPLC-MS. A sample was prepared using acetonitrile protein precipitation.Results and discussion. This method was validated by next validation parameters: selectivity, matrix effect, calibration curve, accuracy, precision, lower limit of quantification, carry-over and stability.Conclusion. The method of the quantitative determination of tadalafil in human plasma was developed and validated by HPLC-MS. The analytical range of the was 5,00–1000,00 ng/ml tadalafil in plasma. Method could be applied to determination of tadalafil in plasma for PK and BE studies.
format Article
id doaj-art-9f3cd559c13b49b7b53deef2c99201f4
institution Kabale University
issn 2305-2066
2658-5049
language Russian
publishDate 2019-05-01
publisher LLC Center of Pharmaceutical Analytics (LLC «CPHA»)
record_format Article
series Разработка и регистрация лекарственных средств
spelling doaj-art-9f3cd559c13b49b7b53deef2c99201f42025-08-20T03:59:20ZrusLLC Center of Pharmaceutical Analytics (LLC «CPHA»)Разработка и регистрация лекарственных средств2305-20662658-50492019-05-018210811410.33380/2305-2066-2019-8-2-108-114676Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS MethodD. S. Bogdanova0T. N. Komarov1I. E. Shohin2E. S. Melnikov3O. A. Miskiv4Yu. V. Medvedev5LLC «CPHA»LLC «CPHA»LLC «CPHA»Clinical Hospital I. V. Davidovsky Department of Health of the city of Moscow; I. M. Sechenov First MSMU MOH Russia (Sechenovskij University)LLC «CPHA»LLC «CPHA»; I. M. Sechenov First MSMU MOH Russia (Sechenovskij University)Introduction. Tadalafil is a drug used to treat erectile dysfunction. For the quantitative determination of tadalafil in human plasma are used methods of high performance liquid chromatography with ultraviolet and tandem mass spectrometric detection, during the analytical part of pharmacokinetic studies. In the majority of the considered methods the method of liquid-liquid extraction and the method of solid-phase extraction are used, these methods are difficult and expensive. Therefore, the method of protein precipitation was considered as sample preparation. This method is simple and there is important to analysis a lot of clinical samples in bioequivalence studies.Aim. The aim of this study is to develop method for the quantitative determination of tadalafil in human plasma by HPLC-MS for the analytical part of pharmacokinetic studies.Materials and methods. Quantitative determination of tadalafil in plasma by HPLC-MS. A sample was prepared using acetonitrile protein precipitation.Results and discussion. This method was validated by next validation parameters: selectivity, matrix effect, calibration curve, accuracy, precision, lower limit of quantification, carry-over and stability.Conclusion. The method of the quantitative determination of tadalafil in human plasma was developed and validated by HPLC-MS. The analytical range of the was 5,00–1000,00 ng/ml tadalafil in plasma. Method could be applied to determination of tadalafil in plasma for PK and BE studies.https://www.pharmjournal.ru/jour/article/view/690tadalafilplasmahplc-msquantitative determinationvalidationbioequivalence
spellingShingle D. S. Bogdanova
T. N. Komarov
I. E. Shohin
E. S. Melnikov
O. A. Miskiv
Yu. V. Medvedev
Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
Разработка и регистрация лекарственных средств
tadalafil
plasma
hplc-ms
quantitative determination
validation
bioequivalence
title Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
title_full Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
title_fullStr Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
title_full_unstemmed Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
title_short Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
title_sort development and validation of tadalafil determination in human plasma by hplc ms method
topic tadalafil
plasma
hplc-ms
quantitative determination
validation
bioequivalence
url https://www.pharmjournal.ru/jour/article/view/690
work_keys_str_mv AT dsbogdanova developmentandvalidationoftadalafildeterminationinhumanplasmabyhplcmsmethod
AT tnkomarov developmentandvalidationoftadalafildeterminationinhumanplasmabyhplcmsmethod
AT ieshohin developmentandvalidationoftadalafildeterminationinhumanplasmabyhplcmsmethod
AT esmelnikov developmentandvalidationoftadalafildeterminationinhumanplasmabyhplcmsmethod
AT oamiskiv developmentandvalidationoftadalafildeterminationinhumanplasmabyhplcmsmethod
AT yuvmedvedev developmentandvalidationoftadalafildeterminationinhumanplasmabyhplcmsmethod